Humana Inc. (HUM) will report its second-quarter 2026 financial results on July 29, prior to the market opening. The Zacks Consensus Estimate for earnings stands at $6.22 per share on revenues of $40.65 billion, reflecting a 25.5% year-over-year revenue growth but a slight decrease of 0.8% in earnings.
For the full year, Humana’s revenue is projected at $162.60 billion, indicating a 25.3% year-over-year rise, while the current-year EPS consensus estimate is $9.25, suggesting a significant decline of approximately 46% compared to the previous year. The company has surpassed earnings estimates in three of the last four quarters, with an average surprise of 3.8%.
Key performance indicators for Q2 2026 include an anticipated 25.6% growth in premiums and 26.6% growth in Medicare memberships. However, total operating costs are expected to rise by 24.4%, potentially impacting the bottom line adversely.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
